BlackRock managed a small gain after attracting $205 billion of new money. ASML and Morgan Stanley both exceeded profit expectations but declined with technology and financial stocks. Bank of America suffered the sharpest drop after a regulatory penalty compounded an underlying earnings miss.
$BlackRock(BLK)$ Record inflows provide rare shelter
BlackRock is the world’s largest asset manager and the owner of the iShares ETF franchise.
Third-quarter revenue rose 19% to $7.75 billion, beating the roughly $7.5 billion consensus. Adjusted EPS jumped 38% to $15.93, well above the $14.13 estimate.
Clients added $205 billion during the quarter, including $134.5 billion into iShares ETFs and $78.2 billion into fixed-income products. Assets under management reached a record $15.49 trillion, up from $13.46 trillion a year earlier.
The shares rose as much as 5% before closing only 0.7% higher on Oct. 14 as the broader market sold off. Investors rewarded the breadth of the inflows and management’s expectation that demand for private-market and yield-oriented investments will keep expanding into 2027.
$Bank of America(BAC)$ A $1.2 billion penalty exposes a weaker quarter
Bank of America is a diversified lender with major consumer-banking, wealth-management and trading operations.
Revenue increased 3% to $29.96 billion, missing the $30.58 billion estimate. Reported EPS was 91 cents. Excluding a regulatory settlement that reduced earnings by 17 cents per share, adjusted EPS of roughly $1.08 still fell short of the $1.10 consensus.
The penalty stemmed from deficiencies in the bank’s anti-money-laundering and sanctions-monitoring systems. Bond-trading revenue also fell about 17%, while investment-banking fees weakened.
Shares sank 4.7%, their worst session in about 18 months. Management maintained its expectation for roughly 8% net-interest-income growth in 2026 and at least that pace in 2027, but the outlook did not offset concerns about compliance costs and weaker capital-markets performance.
$ASML Holding NV(ASML)$ Strong AI demand runs into a broad chip selloff
ASML makes the lithography machines used to produce advanced semiconductors and is the sole supplier of EUV systems.
Third-quarter sales reached a record €11.66 billion. Revenue was slightly below the dollar-based consensus, while earnings equivalent to about $14.50 per ADR comfortably beat the $12.17 estimate. Gross margin climbed to 57.5%.
ASML projected fourth-quarter revenue of €14.2 billion to €15.2 billion and full-year sales of €44 billion to €45 billion. Customers are already discussing orders for 2029 and 2030, and management warned that planned production for 2027 and 2028 may not satisfy demand.
The ADRs fell 3.9%. A modest sales miss and a nearly 4% decline in the semiconductor index outweighed the bullish capacity outlook, particularly after ASML’s strong year-to-date rally.
$Morgan Stanley(MS)$ Equity traders deliver, but the stock follows the market lower
Morgan Stanley combines investment banking and trading with one of the largest U.S. wealth-management platforms.
Net revenue climbed 12% to $20.34 billion, topping the $19.93 billion forecast. EPS of $3.03 also beat expectations of $2.93.
Equity-trading revenue surged 41% to $5.8 billion, and wealth-management revenue reached a record $9.07 billion. Total client assets across wealth and investment management rose to $10.5 trillion. Fixed-income trading was the weak spot, falling about 7%.
Morgan Stanley kept its full-year outlook unchanged. The stock closed 2.8% lower as hotter inflation pressured the market and investors looked past the headline beat to softer bond trading and subdued investment-banking growth.
Today’s discussion:
If you had to buy one after the sell-off, which would you pick?
-
🅰️ ASML — Betting on long-term AI chip demand.
-
🅱️ Morgan Stanley — Betting on Wall Street trading and wealth management.
-
🅲 Neither — I'd wait for a better entry point.
Comments
The market is confusing short-term weakness with deteriorating fundamentals. ASML reported €11.66 billion in Q3 revenue, a 57.5% gross margin, and expects full-year sales of €44–45 billion. Customers are already discussing orders for 2029 and 2030, suggesting AI demand will endure.
Morgan Stanley is also impressive, with equity-trading revenue surging 41% and wealth-management revenue reaching a record $9.07 billion. However, trading income is cyclical, and strong quarterly results may not last.
My conclusion: ASML offers the stronger long-term advantage. Its EUV technology is extraordinarily difficult to replicate, creating a powerful competitive moat. But a great company isn't automatically a great investment at any price.
I'd scale in gradually rather than chase a falling market. The opportunity comes when fear creates a discount—not simply when a stock turns red.
@Tiger_Earnings [得意]
I like ASML more - monopoly EUV, no AI chips without it. MS P/E 14x cheap but if Fed hikes, trading slows. ASML rich at 58x but growth visibility till 2028 is real and they plan 30% capacity expansion. I'd buy dip around 1650 with small size.
Not financial advice.
🅰️ ASML — I’d lean towards ASML for its strategic role in semiconductor manufacturing and long-term AI chip demand. The key is whether the sell-off offers a reasonable valuation, rather than simply buying because the price has fallen. 📈
AI is the cornerstone of the Fourth Industrial Revolution. Like steam or electricity, it is transforming human history. However, instead of scaling physical labor, AI multiplies cognitive ability. The next generation will shift from execution to strategy, managing AI as an invisible utility deeply embedded in daily life.
ASML长期受益于AI芯片需求,但股价下跌不代表估值已经便宜;摩根士丹利的交易和财富管理业务表现不错,也要留意经济环境及市场波动的影响。
如果是我,不会只看财报好就急着买,而会先比较估值、现金流和未来增长。 等价格更合理,再分批布局。投资最重要的不是买在最低点,而是避免买得太贵、承担超出能力的风险。
For Morgan Stanley, I like its diversified business model & wealth management segment, but trading income can fluctuate with market conditions. I would rather invest in a business with a strong competitive advantage & a clear long-term growth driver than rely too heavily on short-term market activity.
Personally, I would not rush to buy either just because they have pulled back. I would keep ASML on my watchlist & look for a more attractive entry point, adding gradually if the valuation becomes reasonable. For me, patience is just as important as picking the right company.
@TigerStars @Tiger_comments @TigerClub @Tiger_Earnings